170 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

« prev | Page of 4 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LRG1Leucine-rich alpha-2-glycoprotein 1Plasma proteins
Predicted secreted proteins
Tissue enriched
SLC6A1Solute carrier family 6 (neurotransmitter transporter), member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
TTC36Tetratricopeptide repeat domain 36Predicted intracellular proteins
Tissue enriched
ABCB11ATP-binding cassette, sub-family B (MDR/TAP), member 11Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CFBComplement factor BDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
CLEC4MC-type lectin domain family 4, member MCD markers
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HNF4AHepatocyte nuclear factor 4, alphaDisease related genes
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Group enriched
SULT1E1Sulfotransferase family 1E, estrogen-preferring, member 1Cancer-related genes
Enzymes
Predicted intracellular proteins
Group enriched
C6Complement component 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Transporters
Group enriched
EHHADHEnoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
GATMGlycine amidinotransferase (L-arginine:glycine amidinotransferase)Disease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
SARDHSarcosine dehydrogenaseDisease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
SORDSorbitol dehydrogenaseEnzymes
Plasma proteins
Predicted intracellular proteins
Group enriched
ACY1Aminoacylase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
ADH1CAlcohol dehydrogenase 1C (class I), gamma polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
AZGP1Alpha-2-glycoprotein 1, zinc-bindingCancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
C3Complement component 3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
GCKRGlucokinase (hexokinase 4) regulatorPredicted intracellular proteins
Tissue enriched
HALHistidine ammonia-lyaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
HSD11B1Hydroxysteroid (11-beta) dehydrogenase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Tissue enriched
PCK2Phosphoenolpyruvate carboxykinase 2 (mitochondrial)Citric acid cycle related proteins
Disease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PZPPregnancy-zone proteinCancer-related genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
RGNRegucalcinEnzymes
Plasma proteins
Predicted intracellular proteins
Group enriched
UGT2B17UDP glucuronosyltransferase 2 family, polypeptide B17Enzymes
Predicted membrane proteins
Group enriched
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Group enriched
ALDH6A1Aldehyde dehydrogenase 6 family, member A1Disease related genes
Enzymes
Mitochondrial proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
ASS1Argininosuccinate synthase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
CLEC4GC-type lectin domain family 4, member GPredicted intracellular proteins
Predicted membrane proteins
Group enriched
CRPC-reactive protein, pentraxin-relatedCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
CYP2C9Cytochrome P450, family 2, subfamily C, polypeptide 9Enzymes
Predicted secreted proteins
Tissue enriched
GAS2Growth arrest-specific 2Predicted intracellular proteins
Tissue enriched
GCGroup-specific component (vitamin D binding protein)Plasma proteins
Predicted secreted proteins
Tissue enriched
HNF1AHNF1 homeobox ACancer-related genes
Predicted intracellular proteins
Group enriched
IGFBP1Insulin-like growth factor binding protein 1Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Group enriched
NPC1L1NPC1-like 1FDA approved drug targets
Predicted membrane proteins
Group enriched
SLC27A2Solute carrier family 27 (fatty acid transporter), member 2Enzymes
Predicted membrane proteins
Transporters
Group enriched
SLC2A2Solute carrier family 2 (facilitated glucose transporter), member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
STAB2Stabilin 2Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
A1CFAPOBEC1 complementation factorPredicted intracellular proteins
Tissue enhanced
ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif, 13Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
APOA1Apolipoprotein A-ICancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
ARG1Arginase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Tissue enhanced
C2Complement component 2Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
CBSCystathionine-beta-synthaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Tissue enhanced
CBSCystathionine-beta-synthasePredicted intracellular proteins
Tissue enhanced
CDO1Cysteine dioxygenase type 1Enzymes
Predicted intracellular proteins
Tissue enhanced
CLDN1Claudin 1Disease related genes
Predicted membrane proteins
Tissue enhanced

« prev | Page of 4 | next »